Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With HNSCC
NCT01864850 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 202
Last updated 2023-09-22
Summary
Randomized comparison between standard radiotherapy and hypofractionated split course schedule. Compared to standard radiotherapy, the investigators expect that hypofractionated split course (interruption of 2 weeks) radiotherapy will improve compliance to treatment, acute tolerance of treatment, preservation of autonomy, prevention of malnutrition, with the same efficacy, measured by the locoregional control rate.
Conditions
Interventions
- RADIATION
-
Standard RT
70 Gy / 7 weeks / 2 Gy per fraction
- RADIATION
-
Hypofractionated RT
55 Gy / 7 weeks with 2 weeks interruption / 3 Gy per fraction until 30 Gy, after interruption 2.5 Gy per fraction until 55 Gy
Sponsors & Collaborators
-
Gustave Roussy, Cancer Campus, Grand Paris
collaborator OTHER -
Groupe Oncologie Radiotherapie Tete et Cou
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-10-18
- Primary Completion
- 2020-06-30
- Completion
- 2020-06-05
Countries
- France
- Monaco
Study Locations
More Related Trials
-
Impact of Hypofractionated Radiotherapy Strategy After Surgery of Skin Carcinomas in Older Patients
NCT05794035 ·Status: RECRUITING ·Phase: NA
-
A Feasibility Study of Adaptive Intensity-Modulated Radiation Therapy
NCT00608751 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck Cancer
NCT04477759 ·Status: COMPLETED ·Phase: PHASE1
-
Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer
NCT05994300 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Radiotherapy of Head and Neck Cancer With SIB
NCT06831903 ·Status: RECRUITING
-
Adaptive, Image-guided, Intensity-modulated Radiotherapy for Head and Neck Cancer in the Reduced Volumes of Elective Neck
NCT01287390 ·Status: COMPLETED ·Phase: PHASE2
-
Adaptive Radiation Therapy for Head & Neck Cancer Patients
NCT01853670 ·Status: COMPLETED ·Phase: NA
-
A Study of Conventional 3D Radiation vs. Intensity-Modulated Radiation in Squamous Cell Cancer of the Head and Neck
NCT00363441 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Stereotactic Body Radiation Therapy or Intensity Modulated Radiation/Proton Therapy in Treating Patients With Recurrent Head and Neck Cancer
NCT03164460 ·Status: SUSPENDED ·Phase: PHASE2
-
Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study
NCT01836692 ·Status: COMPLETED ·Phase: NA
-
Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung Cancer
NCT01459497 ·Status: COMPLETED ·Phase: PHASE3
-
Hypofractionated Adjuvant Radiotherapy for Resected Head and Neck Cancers
NCT05120947 ·Status: COMPLETED ·Phase: NA
-
A Study of Intensity-modulated Radiotherapy in Patients With Squamous Cell Carcinoma of Unknown Primary (SCCUP) of the Head and Neck
NCT02112344 ·Status: COMPLETED ·Phase: NA
-
HN-BIO 02: A Phase II Randomized Study of the Effects of Delayed Elective Radiotherapy on Head and Neck MRI and Immune Response Biomarkers
NCT06487403 ·Status: RECRUITING ·Phase: NA
-
Evaluation of 3DCRT Versus IGRT and Analysis of Early Response in Head and Neck Cancer.
NCT01124409 ·Status: UNKNOWN ·Phase: PHASE3
-
A Feasibility Study On Continuous Adaptive [18f]Fdg-Pet-Guided Radiotherapy For Head and Neck Cancer
NCT01208883 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Adaptive Dose Painting by Numbers With Standard Radiotherapy for Head and Neck Cancer.
NCT01341535 ·Status: COMPLETED ·Phase: PHASE2
-
Adaptative Radiotherapy to Decrease Xerostomia in Oropharynx Carcinoma
NCT01874587 ·Status: COMPLETED ·Phase: PHASE3
-
Stereotactic Radiosurgery in Patients With Head and Neck Region Tumours
NCT06472570 ·Status: RECRUITING ·Phase: NA
-
Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC
NCT06137274 ·Status: RECRUITING ·Phase: PHASE2
-
Margin-Based Vs. Robust Photon Radiotherapy Planning in IMRT of HN-SQCC
NCT03552965 ·Status: COMPLETED ·Phase: NA
-
Phase II Study of Whole or Partial Parotid Sparing Intensity Modulated Radiotherapy in Patients With Head and Neck Cancers
NCT02068313 ·Status: UNKNOWN
-
Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer
NCT07058805 ·Status: RECRUITING ·Phase: PHASE2
-
SBRT + Immunomodulating Systemic Therapy for Inoperable, Recurrent H&N
NCT03402737 ·Status: TERMINATED ·Phase: NA
-
Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer
NCT03035890 ·Status: COMPLETED ·Phase: NA